Trade

with

Baxter International Inc
(NYSE: BAX)
AdChoices
69.10
+0.73
+1.07%
Pre-Market :
69.18
+0.08
+0.12%

Open

68.98

Previous Close

68.37

Volume (Avg)

2.15M (2.40M)

Day's Range

68.95-69.47

52Wk Range

64.78-77.31

Market Cap.

37.43B

Dividend Rate (Yield )

2.08 (2.92%)

Beta

0.72

Shares Outstanding

541.67M

P/E Ratio (EPS)

19.46 (3.55)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 15.26B

    • Net Income

    • 2.01B

    • Market Cap.

    • 37.43B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.90

    • PEG (Price/Earnings Growth) Ratio

    • 2.01

    • Beta

    • 0.72

    • Forward P/E

    • 13.83

    • Price/Sales

    • 2.31

    • Price/Book Value

    • 4.32

    • Price/Cash flow

    • 11.61

      • EBITDA

      • 3.53B

      • Return on Capital %

      • 7.88

      • Return on Equity %

      • 24.41

      • Return on Assets %

      • 7.88

      • Book Value/Share

      • 15.99

      • Shares Outstanding

      • 541.67M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.52 (9/3/2014)

      • Dividend Declaration Date

      • 7/22/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 73.50

        • Credit Rating

        • UR-

        • Analysts

        • 5

        • EPS Estimate

        • 4.36

        • Cashflow Estimate

        • 6.31

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 16.20

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -13.50

          • -15.59

          • Net Income

            Q/Q (last year)

          • -11.90

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 4.32

          • 12.51

          • Net Income

            5-Year Annual Average

          • 0.00

          • 4.16

          • Dividends

            5-Year Annual Average

          • 16.04

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.31

            • 52.83

            • Pre-Tax Margin

            • 15.18

            • 15.96

            • Net Profit Margin

            • 11.90

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 50.10

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 18.80

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 14.80

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.87

              • 0.62

              • Current Ratio

              • 1.64

              • 1.97

              • Quick Ratio

              • 0.82

              • 1.16

              • Interest Coverage

              • 13.73

              • 10.47

              • Leverage Ratio

              • 2.96

              • 2.38

              • Book Value/Share

              • 15.99

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 19.12

                • 35.97

                • P/E Ratio 5-Year High

                • 21.77

                • 279.76

                • P/E Ratio 5-Year Low

                • 11.33

                • 148.87

                • Price/Sales Ratio

                • 2.28

                • 3.33

                • Price/Book Value

                • 4.25

                • 4.16

                • Price/Cash Flow Ratio

                • 11.61

                • 17.27

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 56.04

                    • Dividend Date

                    • 7/22/2014

                    • Ex-Dividend Date

                    • 9/3/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 24.41

                        (29.60)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • 7.88

                        (10.90)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • 12.41

                        (17.80)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • 31.90k

                      • 25.65k

                      • Inventory Turnover

                      • 2.45

                      • 2.66

                      • Asset Turnover

                      • 0.66

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      2.67B
                      Operating Margin
                      17.48
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      11.61
                      Ownership

                      Institutional Ownership

                      87.06%

                      Top 10 Institutions

                      25.88%

                      Mutual Fund Ownership

                      36.02%

                      Float

                      99.84%

                      5% / Insider Ownership

                      0.46%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        8,831,633

                      • 0.45

                      • 1.63

                      • Vanguard Five Hundred Index Fund

                      •  

                        5,623,462

                      • 0.06

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        5,487,537

                      • -1.23

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        5,323,959

                      • 1.58

                      • 0.94

                      • VA CollegeAmerica Income Fund of America

                      •  

                        4,025,000

                      • 50.47

                      • 0.74

                      • VA CollegeAmerica Fundamental Investors

                      •  

                        3,751,755

                      • 0.00

                      • 0.69

                      • Vanguard Windsor™ II Fund

                      •  

                        3,370,600

                      • 0.00

                      • 0.62

                      • BBH Core Select Fund

                      •  

                        2,895,286

                      • 0.00

                      • 0.54

                      • VA CollegeAmerica Growth Fund of America

                      •  

                        2,818,910

                      • 0.00

                      • 0.52

                      • AllianzGI NFJ Dividend Value Fund

                      •  

                        2,462,500

                      • 0.00

                      • 0.45

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        27,325,319

                      • +1.82%

                      • 5.04

                      • State Street Corp

                      •  

                        24,490,581

                      • +1.63%

                      • 4.52

                      • BlackRock Fund Advisors

                      •  

                        19,271,703

                      • +2.04%

                      • 3.56

                      • Aberdeen Asset Management PLC

                      •  

                        13,502,069

                      • +2.64%

                      • 2.49

                      • State Farm Mutual Automobile Ins CO

                      •  

                        13,240,194

                      • 0.00%

                      • 2.44

                      • Capital World Investors

                      •  

                        12,622,784

                      • -4.87%

                      • 2.33

                      • Brown Brothers Harriman & Co

                      •  

                        11,876,261

                      • -0.82%

                      • 2.19

                      • Northern Trust Investments, N.A.

                      •  

                        9,915,220

                      • -3.35%

                      • 1.83

                      • Merrill Lynch & Co Inc

                      •  

                        8,037,470

                      • +177.69%

                      • 1.48

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Classic Growth

                      Style

                      Large Core

                      Baxter International Inc is a Delaware corporation incorporated in 1931. The Company is a healthcare company engaged in the development, manufacture and sale of products that save and sustain the lives of people with hemophilia, immu...morene disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company applies a combination of medical devices, pharmaceuticals and biotechnology to create products that advance patient care. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in two segments namely BioScience and Medical Products. The BioScience business processes recombin...moreant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as bio surgery products; and vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies. The business manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic. The Company has its own direct sales force and also makes sales to and through independent distributors, drug wholesalers acting as sales agents and specialty pharmacy or other alternate site providers. The Company faces substantial competition in each of its segments from international and domestic healthcare and pharmaceutical companies of all sizes. The BioScience segment faces competitors from pharmaceutical, biotechnology and other companies. The Medical Products segment faces competition from medical device manufacturers and pharmaceutical companies. The Company’s operations and many of the products manufactured or sold by the Company are subject to extensive regulation by numerous government agencies, both within and outside the United States.lessless

                      Key People

                      Robert L. Parkinson,Jr

                      CEO/Chairman of the Board/Director

                      Mr. Robert J. Hombach

                      CFO/Vice President

                      Jean-Luc Butel

                      President, Divisional/Vice President

                      Jeanne K. Mason

                      Vice President, Divisional

                      Mr. David P. Scharf

                      General Counsel/Vice President/Secretary

                      • Baxter International Inc

                      • One Baxter Parkway

                      • Deerfield, IL 60015

                      • USA.Map

                      • Phone: +1 224 948-2000

                      • Fax: -

                      • baxter.com

                      Incorporated

                      1931

                      Employees

                      61,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: